Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: a single-institution experience

Table 2 Clinical characteristics of 32 patients and their outcome

Patient number	Age range at presentation	Age range at metastases	Tumor diameter (cm)	pT-stage	pN-stage	M-stage	Site of metastases	Tg at diagnosis of metastases	Survival	Disease-free interval	Survival from diagnosis of distant metastases	Cause of death
1	85–89	85–89	7,5	3	0	1	L	7414	77	0	77	DDM
2	75–79	75–79	5	4b	0	1	L	4450	53	0	53	DOC
3	70–74	70–74	8	3	0	1	L	265	141	0	141	DDM
4	70–74	70–74	6	4a	0	1	B	183	13	0	13	DDM
5	65–69	65–69	8,5	3	0	1	L	16650	185	0	185	Alive
6	65–69	65–69	8	3	0	1	BL	4010	148	0	148	DDM
7	60–64	60–64	8	0	0	1	B	No data	153	0	153	DDM
8	60–64	60–64	4,5	3	1b	1	L	62600	131	0	131	DDM
9	60–64	60–64	2	2	0	1	B	69	1	0	1	LFU
10	60–64	60–64	6,5	3	0	1	L	1300	72	0	72	DDM
11	55–59	55–59	5	4b	1b	1	L	190	201	0	201	DDM
12	45–49	45–49	9	4b	0	1	L	5800	52	0	52	DDM
13	85–89	85–89	12	3	0	0	Mediastinum	277	52	38	14	DDM
14	75–79	75–79	3	2	0	0	B	47	126	34	92	Alive
15	75–79	85–89	8	3	0	0	L	696	144	84	60	DDM
16	70–74	70–74	2	4a	1a	0	Kidney	1432	318	180	138	DDM
17	70–74	75–79	8	3	0	0	L	1300	63	36	2	DDLTP
18	70–74	80–84	6,8	3	0	0	L	1000	132	96	36	Alive
19	70–74	70–74	5,5	4a	0	0	L	No data	26	3	23	DDM
20	65–69	65–69	3,6	3	0	0	L	0.1	46	43	3	Alive
21	65–69	70–74	7	4a	0	0	L	No data	63	53	10	DDM
22	65–69	65–69	9	3	0	0	BL	1100	145	52	93	DDM
23	60–64	65–69	18	4b	1b	0	L	416	100	20	53	DDM
24	60–64	70–74	3	2	0	0	L, liver	501	121	84	36	DDM
25	60–64	65–69	4,5	3	0	0	L	30773	97	49	48	Alive
26	60–64	70–74	7	3	0	0	L	196	138	113	27	Alive
27	60–64	60–64	6,5	3	1a	0	B	763	43	16	27	Alive
28	60–64	60–64	8	4a	0	0	Mediastinum	1800	145	44	101	DDLTP
29	50–54	55–59	13	4b	0	0	L	800	75	26	42	DDM
30	50–54	75–79	6	3	0	0	L	163	337	31	65	DDM
31	50–54	50–54	3	2	1b	0	L	Tg-antibodies	33	9	24	Alive
32	35–39	40–44	4	3	0	0	BL	108	286	60	226	Alive

Legend: B bone, L lungs, DDM dead of distant metastases, DOC dead of other causes, LFU lost to follow-up, DDLTP dead of distant and locoregional tumor progression

ISSN: 1471-2407